We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BRUKER

BRUKER offers high-performance scientific instruments and high-value analytical and diagnostic solutions that enable ... read more Featured Products: More products

Download Mobile App




Cutaneous Leishmaniasis Species Identified by Mass Spectrometry

By LabMedica International staff writers
Posted on 18 Jun 2014
Cutaneous leishmaniasis (CL) is caused by several Leishmania species that are associated with variable outcomes before and after therapy and optimal treatment decision is based on an accurate identification of the infecting species.

Current methods to type Leishmania isolates are relatively complex and slow and therefore, the initial treatment decision is generally presumptive, the infecting species being suspected on epidemiological and clinical grounds. More...
A simple method to type cultured isolates would facilitate disease management.

Scientists at the University Pierre et Marie Curie (Paris, France) performed parasitological diagnosis and analysis by lesion scraping, biopsy or aspirate followed by direct examination of Giemsa-stained smears, histological analysis, Giemsa-stained tissue sections, culture or polymerase chain reaction (PCR). They also analyzed promastigote pellets from 46 strains cultured in monophasic medium, including 20 short-term cultured isolates from French travelers, 19 with CL, and one with visceral leishmaniasis and clinical isolates were analyzed in parallel with Multilocus Sequence Typing (MLST).

The promastigote pellets were analyzed by Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) technology and performed on a BrukerAutoflex I MALDI-TOF mass spectrometer (Bruker-Daltonics, Bremen, Germany). Automatic dendrogram analysis generated a classification of isolates consistent with reference determination of species based on MLST or 70 kDa heat shock protein gene (hsp70) sequencing. An analysis of the spectra, based on a very simple, database-independent analysis of spectra, showed that the mutually exclusive presence of two pairs of peaks discriminated isolates considered by reference methods to belong either to the Viannia or Leishmania subgenus, and that within each subgenus presence or absence of a few peaks allowed discrimination to species complexes level.

The authors concluded that analysis of cultured Leishmania isolates using mass spectrometry allows a rapid and simple classification to the species complex level consistent with reference methods, a potentially useful method to guide treatment decision in patients with cutaneous leishmaniasis. The intuitive interpretation of spectra was well-suited for allowing for close interactions between parasitologists and clinicians. The study was published on June 5, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University Pierre et Marie Curie
Bruker-Daltonics



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.